Bright fluorescence monitoring system utilizing zoanthus sp. green fluorescent protein (ZsGreen) for human g-protein-coupled receptor signaling in microbial yeast cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Nakamura, Yasuyuki ^a   Ishii, Jun ^a   Kondo, Akihiko ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GREEN FLUORESCENT PROTEIN; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; BRIGHTNESS; CELL SURFACE DISPLAY; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; FLUORESCENCE MICROSCOPY; FUNGAL CELL WALL; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING ASSAY; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; YEAST CELL;

ANEMONE; ANIMALS; GREEN FLUORESCENT PROTEINS; HUMANS; RECEPTORS, NEUROTENSIN; RECEPTORS, SOMATOSTATIN; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

EID: 84891914957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082237     Document Type: Article

References (65)

1. Fredriksson R, Lagerström MC, Lundin LG, Schiöth HB (2003) The Gprotein- coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272. doi:10.1124/mol.63.6.1256. PubMed: 12761335. (Pubitemid 36627220)
2. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS et al. (2007) Crystal structure of the human beta2 adrenergic G-proteincoupled receptor. Nature 450: 383-387. doi:10.1038/nature06325. PubMed: 17952055. (Pubitemid 350126755)
3. Cotton M, Claing A (2009) G protein-coupled receptors stimulation and the control of cell migration. Cell Signal 21: 1045-1053. doi:10.1016/ j.cellsig.2009.02.008. PubMed: 19249352.
4. Gudermann T, Nürnberg B, Schultz G (1995) Receptors and G proteins as primary components of transmembrane signal transduction. Part 1. G-protein-coupled receptors: structure and function. J Mol Med (Berl) 73: 51-63. doi:10.1007/BF00270578. PubMed: 7627630.
5. Ishii J, Fukuda N, Tanaka T, Ogino C, Kondo A (2010) Protein-protein interactions and selection: yeast-based approaches that exploit guanine nucleotide-binding protein signaling. FEBS J 277: 1982-1995. doi:10.1111/j.1742-4658.2010.07625.x. PubMed: 22428173.
6. Iguchi Y, Ishii J, Nakayama H, Ishikura A, Izawa K et al. (2010) Control of signalling properties of human somatostatin receptor subtype-5 by additional signal sequences on its amino-terminus in yeast. J Biochem 147: 875-884. doi:10.1093/jb/mvq023. PubMed: 20207822.
7. Togawa S, Ishii J, Ishikura A, Tanaka T, Ogino C et al. (2010) Importance of asparagine residues at positions 13 and 26 on the amino-terminal domain of human somatostatin receptor subtype-5 in signalling. J Biochem 147: 867-873. doi:10.1093/jb/mvq022. PubMed: 20207824.
8. Li B, Scarselli M, Knudsen CD, Kim SK, Jacobson KA et al. (2007) Rapid identification of functionally critical amino acids in a G proteincoupled receptor. Nat Methods 4: 169-174. doi:10.1038/nmeth990. PubMed: 17206152. (Pubitemid 46454686)
9. Ishii J, Moriguchi M, Hara KY, Shibasaki S, Fukuda H et al. (2012) Improved identification of agonist-mediated G?(i)-specific human Gprotein- coupled receptor signaling in yeast cells by flow cytometry. Anal Biochem 426: 129-133. doi:10.1016/j.ab.2012.04.012. PubMed: 22504120.
10. Fukuda N, Ishii J, Kaishima M, Kondo A (2011) Amplification of agonist stimulation of human G-protein-coupled receptor signaling in yeast. Anal Biochem 417: 182-187. doi:10.1016/j.ab.2011.06.006. PubMed: 21726523.
11. Klein C, Paul JI, Sauvé K, Schmidt MM, Arcangeli L et al. (1998) Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat Biotechnol 16: 1334-1337. doi: 10.1038/4310. PubMed: 9853614. (Pubitemid 28547443)
12. Ladds G, Goddard A, Davey J (2005) Functional analysis of heterologous GPCR signaling pathways in yeast. Trends Biotechnol 23: 367-373. doi:10.1016/j.tibtech.2005.05.007. PubMed: 15923053. (Pubitemid 40835767)
13. Evans BJ, Wang Z, Broach JR, Oishi S, Fujii N et al. (2009) Expression of CXCR4, a G-protein-coupled receptor for CXCL12 in yeast identification of new-generation inverse agonists. Methods Enzymol 460: 399-412. doi:10.1016/S0076-6879(09)05220-3. PubMed: 19446737.
14. Ueda M, Tanaka A (2000) Genetic immobilization of proteins on the yeast cell surface. Biotechnol Adv 18: 121-140. doi:10.1016/ S0734-9750(00)00031-8. PubMed: 14538113. (Pubitemid 30390784)
15. Kondo A, Ueda M (2004) Yeast cell-surface display-applications of molecular display. Appl Microbiol Biotechnol 64: 28-40. doi:10.1007/ s00253-003-1492-3. PubMed: 14716465 (Pubitemid 38392150)
16. Shibasaki S, Maeda H, Ueda M (2009) Molecular display technology using yeast-arming technology. Anal Sci 25: 41-49. doi:10.2116/ analsci.25.41. PubMed: 19139571.
17. Gai SA, Wittrup KD (2007) Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol 17: 467-473. doi:10.1016/j.sbi.2007. 08.012. PubMed: 17870469. (Pubitemid 47454774)
18. Pepper LR, Cho YK, Boder ET, Shusta EV (2008) A decade of yeast surface display technology: where are we now? Comb Chem High Throughput Screen 11: 127-134. doi:10.2174/138620708783744516. PubMed: 18336206. (Pubitemid 351347217)
19. Murai T, Ueda M, Atomi H, Shibasaki Y, Kamasawa N et al. (1997) Genetic immobilization of cellulase on the cell surface of Saccharomyces cerevisiae. Appl Microbiol Biotechnol 48: 499-503. doi: 10.1007/s002530051086. PubMed: 9390459. (Pubitemid 27475288)
20. Sato N, Matsumoto T, Ueda M, Tanaka A, Fukuda H et al. (2002) Long anchor using Flo1 protein enhances reactivity of cell surface-displayed glucoamylase to polymer substrates. Appl Microbiol Biotechnol 60: 469-474. doi:10.1007/s00253-002-1121-6. PubMed: 12466889. (Pubitemid 35435818)
21. Nakamura Y, Shibasaki S, Ueda M, Tanaka A, Fukuda H et al. (2001) Development of novel whole-cell immunoadsorbents by yeast surface display of the IgG-binding domain. Appl Microbiol Biotechnol 57: 500- 505. doi:10.1007/s002530100802. PubMed: 11762595. (Pubitemid 33044125)
22. Feldhaus MJ, Siegel RW, Opresko LK, Coleman JR, Feldhaus JM et al. (2003) Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat Biotechnol 21: 163-170. doi:10.1038/nbt785. PubMed: 12536217. (Pubitemid 36188215)
23. Ishii J, Yoshimoto N, Tatematsu K, Kuroda S, Ogino C et al. (2012) Cell wall trapping of autocrine peptides for human G-protein-coupled receptors on the yeast cell surface. PLOS ONE 7: e37136. doi:10.1371/ journal.pone.0037136. PubMed: 22623985.
24. Hara K, Ono T, Kuroda K, Ueda M (2012) Membrane-displayed peptide ligand activates the pheromone response pathway in Saccharomyces cerevisiae. J Biochem 151: 551-557. doi:10.1093/jb/mvs027. PubMed: 22406406.
25. Fukutani Y, Nakamura T, Yorozu M, Ishii J, Kondo A et al. (2012) The N-terminal replacement of an olfactory receptor for the development of a yeast-based biomimetic odor sensor. Biotechnol Bioeng 109: 205- 212. doi:10.1002/bit.23327. PubMed: 21915853.
26. Boder ET, Wittrup KD (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15: 553-557. doi: 10.1038/nbt0697-553. PubMed: 9181578. (Pubitemid 27251573)
27. Fukuda N, Ishii J, Shibasaki S, Ueda M, Fukuda H et al. (2007) Highefficiency recovery of target cells using improved yeast display system for detection of protein-protein interactions. Appl Microbiol Biotechnol 76: 151-158. doi:10.1007/s00253-007-0977-x. PubMed: 17503034. (Pubitemid 47194672)
28. Medico E, Gambarotta G, Gentile A, Comoglio PM, Soriano P (2001) A gene trap vector system for identifying transcriptionally responsive genes. Nat Biotechnol 19: 579-582. doi:10.1038/89343. PubMed: 11385465. (Pubitemid 32521192)
29. Stoeckius M, Maaskola J, Colombo T, Rahn HP, Friedl̈nder MR et al. (2009) Large-scale sorting of C. elegans embryos reveals the dynamics of small RNA expression. Nat Methods 6: 745-751. doi:10.1038/nmeth.1370. PubMed: 19734907.
30. Aharoni A, Thieme K, Chiu CP, Buchini S, Lairson LL et al. (2006) High-throughput screening methodology for the directed evolution of glycosyltransferases. Nat Methods 3: 609-614. doi:10.1038/nmeth899. PubMed: 16862135. (Pubitemid 44123427)
31. Ishii J, Oda A, Togawa S, Fukao A, Fujiwara T, et al.. Microbial fluorescence sensing for human neurotensin receptor type 1 using G?- engineered yeast cells. Anal Biochem. doi: 10.1016/j.ab.2013.10.016. In press. [Online 17 Oct 2013]
32. Ishii J, Matsumura S, Kimura S, Tatematsu K, Kuroda S et al. (2006) Quantitative and dynamic analyses of G protein-coupled receptor signaling in yeast using Fus1, enhanced green fluorescence protein (EGFP), and His3 fusion protein. Biotechnol Prog 22: 954-960. doi: 10.1021/bp0601387. PubMed: 16889369. (Pubitemid 44230681)
33. Elion EA, Satterberg B, Kranz JE (1993) FUS3 phosphorylates multiple components of the mating signal transduction cascade: evidence for STE12 and FAR1. Mol Biol Cell 4: 495-510. doi:10.1091/mbc.4.5.495. PubMed: 8334305. (Pubitemid 23150914)
34. Ishii J, Tanaka T, Matsumura S, Tatematsu K, Kuroda S et al. (2008) Yeast-based fluorescence reporter assay of G protein-coupled receptor signalling for flow cytometric screening: FAR1-disruption recovers loss of episomal plasmid caused by signalling in yeast. J Biochem 143: 667-674. doi:10.1093/jb/mvn018. PubMed: 18281298. (Pubitemid 351670655)
35. Nakamura Y, Ishii J, Kondo A (2013) Rapid, facile detection of heterodimer partners for target human G-protein-coupled receptors using a modified split-ubiquitin membrane yeast two-hybrid system. PLOS ONE 8: e66793. doi:10.1371/journal.pone.0066793. PubMed: 23805278.
36. Nakamura Y, Takemoto N, Ishii J, Kondo A Simultaneous method for analyzing dimerization and signaling of G-protein-coupled receptor in yeast by dual-color reporter system. Biotechnol Bioeng. doi: 10.1002/ bit.25125. In press. [Online 28 Oct 2013]
37. Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG et al. (1999) Fluorescent proteins from nonbioluminescent Anthozoa species. Nat Biotechnol 17: 969-973. doi:10.1038/13657. PubMed: 10504696. (Pubitemid 29474851)
38. Hasegawa S, Maruyama K, Takenaka H, Furukawa T, Saga T (2009) A medaka model of cancer allowing direct observation of transplanted tumor cells in vivo at a cellular-level resolution. Proc Natl Acad Sci U S A 106: 13832-13837. doi:10.1073/pnas.0903999106. PubMed: 19666513.
39. Wan CK, Shaikh SB, Green CR, Nicholson LF (2012) Comparison of bidirectional and bicistronic inducible systems for coexpression of connexin genes and fluorescent reporters. Anal Biochem 431: 90-95. doi:10.1016/j.ab.2012. 08.016. PubMed: 22929700.
40. Raynor K, Murphy WA, Coy DH, Taylor JE, Moreau JP et al. (1993) Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol 43: 838-844. PubMed: 8100350. (Pubitemid 23178857)
41. Raynor K, O'Carroll AM, Kong H, Yasuda K, Mahan LC et al. (1993) Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol Pharmacol 44: 385-392. PubMed: 8102785. (Pubitemid 23252245)
42. Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J et al. (2005) Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med 11: 434-439. doi: 10.1038/nm1206. PubMed: 15778722. (Pubitemid 40562335)
43. Lamberts SW, de Herder WW, Krenning EP, Reubi JC (1994) A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome. J Clin Endocrinol Metab 78: 17-19. doi:10.1210/jc.78.1.17. PubMed: 7904612. (Pubitemid 24026739)
44. Ben-Shlomo A, Melmed S (2008) Somatostatin agonists for treatment of acromegaly. Mol Cell Endocrinol 286: 192-198. doi:10.1016/j.mce.2007.11.024. PubMed: 18191325.
45. Brown AJ, Dyos SL, Whiteway MS, White JH, Watson MA et al. (2000) Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein alpha-subunit chimeras. Yeast 16: 11-22. doi:10.1002/ (SICI)1097-0061(20000115)16:1. PubMed: 10620771. (Pubitemid 30066092)
46. Yu L, Qi M, Sheff MA, Elion EA (2008) Counteractive control of polarized morphogenesis during mating by mitogen-activated protein kinase Fus3 and G1 cyclin-dependent kinase. Mol Biol Cell 19: 1739- 1752. doi:10.1091/mbc.E07-08- 0757. PubMed: 18256288. (Pubitemid 351805125)
47. Carraway R, Leeman SE (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248: 6854-6861. PubMed: 4745447.
48. White JF, Noinaj N, Shibata Y, Love J, Kloss B et al. (2012) Structure of the agonist-bound neurotensin receptor. Nature 490: 508-513. doi: 10.1038/nature11558. PubMed: 23051748.
49. Bissette G, Nemeroff CB, Loosen PT, Prange AJ Jr, Lipton MA (1976) Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature 262: 607-609. doi:10.1038/262607a0. PubMed: 8728.
50. Carraway RE, Plona AM (2006) Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 27: 2445-2460. doi:10.1016/j.peptides.2006.04.030. PubMed: 16887236. (Pubitemid 44402788)
51. Griebel G, Holsboer F (2012) Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov 11: 462-478. doi:10.1038/nrd3702. PubMed: 22596253.
52. Kitabgi P (2002) Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Curr Opin Drug Discov Devel 5: 764-776. PubMed: 12630297. (Pubitemid 36253796)
53. Schimpff RM, Avard C, Fénelon G, Lhiaubet AM, Tennezé L et al. (2001) Increased plasma neurotensin concentrations in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 70: 784-786. doi: 10.1136/jnnp.70.6.784. PubMed: 11385014. (Pubitemid 32554210)
54. Tanaka K, Masu M, Nakanishi S (1990) Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4: 847-854. doi:10.1016/0896- 6273(90)90137-5. PubMed: 1694443. (Pubitemid 20208510)
55. Chalon P, Vita N, Kaghad M, Guillemot M, Bonnin J et al. (1996) Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett 386: 91-94. doi:10.1016/0014-5793(96)00397-3. PubMed: 8647296. (Pubitemid 26173063)
56. Mazella J (2001) Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking? Cell Signal 13: 1-6. doi:10.1016/S0898-6568(00)00130-3. PubMed: 11257441. (Pubitemid 32222966)
57. Barroso S, Richard F, Nicolas-Ethève D, Reversat JL, Bernassau JM et al. (2000) Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1. J Biol Chem 275: 328-336. doi:10.1074/jbc.275.1.328. PubMed: 10617622. (Pubitemid 30038989)
58. Granier C, van Rietschoten J, Kitabgi P, Poustis C, Freychet P (1982) Synthesis and characterization of neurotensin analogues for structure/ activity relationship studies. Acetyl-neurotensin-(8-13) is the shortest analogue with full binding and pharmacological activities. Eur J Biochem 124: 117-124. doi:10.1111/j.1432-1033.1982.tb05913.x. PubMed: 7084220. (Pubitemid 12094720)
59. Kislauskis E, Bullock B, McNeil S, Dobner PR (1988) The rat gene encoding neurotensin and neuromedin N. Structure, tissue-specific expression, and evolution of exon sequences. J Biol Chem 263: 4963- 4968. PubMed: 2832414.
60. Minamino N, Kangawa K, Matsuo H (1984) Neuromedin N: a novel neurotensin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 122: 542-549. doi:10.1016/ S0006-291X(84)80067-4. PubMed: 6547840. (Pubitemid 14060641)
61. Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4: 67-73. doi: 10.1177/108705719900400206. PubMed: 10838414. (Pubitemid 29278954)
62. Ishii J, Izawa K, Matsumura S, Wakamura K, Tanino T et al. (2009) A simple and immediate method for simultaneously evaluating expression level and plasmid maintenance in yeast. J Biochem 145: 701-708. doi: 10.1093/jb/mvp028. PubMed: 19237442.
63. Brachmann CB, Davies A, Cost GJ, Caputo E, Li J et al. (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14: 115-132. doi:10.1002/ (SICI)1097-0061(19980130)14:2. PubMed: 9483801. (Pubitemid 28062863)
64. Gietz D, St Jean A, Woods RA, Schiestl RH (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20: 1425. doi:10.1093/nar/20.6.1425. PubMed: 1561104.
65. Akada R, Kitagawa T, Kaneko S, Toyonaga D, Ito S et al. (2006) PCRmediated seamless gene deletion and marker recycling in Saccharomyces cerevisiae. Yeast 23: 399-405. doi:10.1002/yea.1365. PubMed: 16598691.